ConductScience.org, home

Paper23977965

High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.

Versiani FG and 13 others. Malar J, 2013. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms. Papers, record 23977965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23977965

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.
PubMed
Journal
Malar J
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.03
iCite
Revised in PubMed
2021-10-21
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Versiani FGFernanda G
2Almeida MEMaria E M
3Melo GCGisely C
4Versiani FOFrancivaldo O L
5Orlandi PPPatrícia P
6Mariúba LALuís André M
7Soares LALeidiane A
8Souza LPLuciana P
9da Silva Balieiro AAAntonio A
10Monteiro WMWuelton M
11Costa FTFabio T M
12del Portillo HAHernando A
13Lacerda MVMarcus V G
14Nogueira PAPaulo A

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ProtozoanMajor topic
Immunoglobulin GMajor topic
Malaria, VivaxMajor topic
Merozoite Surface Protein 1Major topic
Adolescent
Adult
Asymptomatic Diseases
Brazil
Child
Child, Preschool
Cross-Sectional Studies
Female
Humans
Infant
Infant, Newborn
Longitudinal Studies
Male
Microscopy
Parasitemia
Prospective Studies
Rural Population
Survival Analysis
Young Adult

Source PubMed

Download CSV of topics

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17629503Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.J Exp Med1995https://conductscience.org/library/papers/7629503PubMed
211160024Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.Infect Immun2001https://conductscience.org/library/papers/11160024PubMed
319091043Plasmodium vivax: who cares?Malar J2008https://conductscience.org/library/papers/19091043PubMed
420092651Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.Malar J2010https://conductscience.org/library/papers/20092651PubMed
59234786Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria.Infect Immun1997https://conductscience.org/library/papers/9234786PubMed
612466500Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12466500PubMed
721862998Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.Mol Ther2011https://conductscience.org/library/papers/21862998PubMed
816622209A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.Infect Immun2006https://conductscience.org/library/papers/16622209PubMed
917699838Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians.Clin Vaccine Immunol2007https://conductscience.org/library/papers/17699838PubMed
1011180119Fixed, epitope-specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in humans living in a malaria-endemic area.Eur J Immunol2001https://conductscience.org/library/papers/11180119PubMed
111343729Human IgG responses against the N-terminal region of the Merozoite Surface Protein 1 of Plasmodium vivax.Mem Inst Oswaldo Cruz1992https://conductscience.org/library/papers/1343729PubMed
1222949516Single-nucleotide polymorphism and copy number variation of the multidrug resistance-1 locus of Plasmodium vivax: local and global patterns.Am J Trop Med Hyg2012https://conductscience.org/library/papers/22949516PubMed
1318212081Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific.Infect Immun2008https://conductscience.org/library/papers/18212081PubMed
1421189324Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies.Infect Immun2011https://conductscience.org/library/papers/21189324PubMed
1522202121
Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.
Infect Immun2012https://conductscience.org/library/papers/22202121PubMed
1615583293Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays.J Clin Microbiol2004https://conductscience.org/library/papers/15583293PubMed
1715275050A hypothesis about the chronicity of malaria infection.Parasitol Today1997https://conductscience.org/library/papers/15275050PubMed
1818958278Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.PLoS One2008https://conductscience.org/library/papers/18958278PubMed
1921292879Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.Am J Trop Med Hyg2011https://conductscience.org/library/papers/21292879PubMed
2019805526Inhibition of erythrocyte invasion and Plasmodium falciparum merozoite surface protein 1 processing by human immunoglobulin G1 (IgG1) and IgG3 antibodies.Infect Immun2009https://conductscience.org/library/papers/19805526PubMed

See all 56 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
41684541B-cell epitope mapping and characterization of antibody responses to recombinant PvRipr in malaria-exposed individuals.Front Immunol2025https://conductscience.org/library/papers/41684541PubMed
39886087IgM against Merozoite Surface Protein 1-Block 2 Haplotypes as New Tools for Plasmodium vivax Infections.J Glob Infect Dis2024https://conductscience.org/library/papers/39886087PubMed
35060185The role of naturally acquired antimalarial antibodies in subclinical Plasmodium spp. infection.J Leukoc Biol2022https://conductscience.org/library/papers/35060185PubMed
34082763Naturally induced humoral response against Plasmodium vivax reticulocyte binding protein 2P1.Malar J2021https://conductscience.org/library/papers/34082763PubMed
32092122Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies.PLoS Pathog2020https://conductscience.org/library/papers/32092122PubMed
31770108Anti-MSP-10 IgG indicates recent exposure to Plasmodium vivax infection in the Peruvian Amazon.JCI Insight2020https://conductscience.org/library/papers/31770108PubMed
31596312A simple, ex vivo phagocytosis assay of Plasmodium vivax merozoites by flow cytometry.Mem Inst Oswaldo Cruz2019https://conductscience.org/library/papers/31596312PubMed
28651021Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.PLoS One2017https://conductscience.org/library/papers/28651021PubMed
28270152A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection.Malar J2017https://conductscience.org/library/papers/28270152PubMed
28243235What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?Front Immunol2017https://conductscience.org/library/papers/28243235PubMed
28202065Alternative transmission routes in the malaria elimination era: an overview of transfusion-transmitted malaria in the Americas.Malar J2017https://conductscience.org/library/papers/28202065PubMed
28133811Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Immunol Rev2017https://conductscience.org/library/papers/28133811PubMed
27581163Immune response pattern in recurrent Plasmodium vivax malaria.Malar J2016https://conductscience.org/library/papers/27581163PubMed
27255376Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1).Malar J2016https://conductscience.org/library/papers/27255376PubMed
27014875Antibody Profiling in Naïve and Semi-immune Individuals Experimentally Challenged with Plasmodium vivax Sporozoites.PLoS Negl Trop Dis2016https://conductscience.org/library/papers/27014875PubMed
26833236Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria.FEMS Microbiol Rev2016https://conductscience.org/library/papers/26833236PubMed
26788998In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.PLoS One2016https://conductscience.org/library/papers/26788998PubMed
26390924A systematic review of sub-microscopic Plasmodium vivax infection.Malar J2015https://conductscience.org/library/papers/26390924PubMed
26034211Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.Infect Immun2015https://conductscience.org/library/papers/26034211PubMed
25569135Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors.PLoS Negl Trop Dis2015https://conductscience.org/library/papers/25569135PubMed

See all 25 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IGHG33502PubTator's text mininghttps://conductscience.org/library/genes/3502

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23977965

GET https://conductscience.org/api/papers/v1/23977965/references?page=2